Literature DB >> 12766645

Temporal summation governs part of the minimum alveolar concentration of isoflurane anesthesia.

Robert C Dutton1, Yi Zhang, Caroline R Stabernack, Michael J Laster, James M Sonner, Edmond I Eger.   

Abstract

BACKGROUND: General anesthesia may delay the onset of movement in response to noxious stimulation. The authors hypothesized that the production of immobility could involve depression of time-related processes involved in the generation of movement.
METHODS: The delays (latencies) between onset of tail clamp (n = 16) or 50-Hz continuous electrical stimulation (n = 8) and movement were measured in rats equilibrated at 0.1-0.2% increasing steps of isoflurane. In other rats (n = 8), the isoflurane concentrations just permitting and preventing movement (crossover concentrations) in response to trains of 0.5-ms 50-V square-wave pulses of interstimulus intervals of 10, 3, 1, 0.3, or 0.1 s during the step increases were measured. These measures were again made during administration of intravenous MK801, an N-methyl-D-aspartate receptor antagonist that can block temporal summation (n = 6). Temporal summation refers to the cumulative effect of repeated stimuli. Crossover concentrations to 10- and 0.1-s interstimulus interval pulses ranging in voltage from 0.25-50 V were also measured (n = 4).
RESULTS: The increase in concentrations from 0.6 to nearly 1.0 minimum alveolar concentration progressively increased latency from less than 1 s to 58 s. Shortening the interstimulus interval (50 V) pulses from 10 to 0.1 s progressively increased crossover concentrations from 0.6 to 1.0 minimum alveolar concentration. In contrast, during MK801 administration shortening interstimulus intervals did not change crossover concentrations, producing a flat response to change in the interstimulus interval. Increasing the voltage of interstimulus interval pulses increased the crossover concentrations but did not change the response to change in interstimulus intervals for pulses greater than 1 V.
CONCLUSIONS: Increasing the duration or frequency (interstimulus interval) of stimulation increases the concentration of isoflurane required to suppress movement by a 0.4 minimum alveolar concentration MK801 blocks this effect, a finding consistent with temporal summation (which requires intact N-methyl-D-aspartate receptor activity) at concentrations of up to 1 minimum alveolar concentration isoflurane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766645     DOI: 10.1097/00000542-200306000-00011

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Selective blockade of N-methyl-D-aspartate channels in combination with dopamine receptor antagonism induces loss of the righting reflex in mice, but not immobility.

Authors:  Nobuhito Kikuchi; Masahiro Irifune; Yoshitaka Shimizu; Keita Yoshida; Katsuya Morita; Takashi Kanematsu; Norimitsu Morioka; Yoshihiro Nakata; Norio Sakai
Journal:  Psychopharmacology (Berl)       Date:  2014-05-31       Impact factor: 4.530

2.  Prior determination of baseline minimum alveolar concentration (MAC) of isoflurane does not influence the effect of ketamine on MAC in rabbits.

Authors:  Giacomo Gianotti; Alexander Valverde; Melissa Sinclair; Doris H Dyson; Thomas Gibson; Ron Johnson
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

3.  General anesthetics have additive actions on three ligand gated ion channels.

Authors:  Andrew Jenkins; Ingrid A Lobo; Diane Gong; James R Trudell; Ken Solt; R Adron Harris; Edmond I Eger
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

Review 4.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

Review 5.  The Effects of General Anesthetics on Synaptic Transmission.

Authors:  Xuechao Hao; Mengchan Ou; Donghang Zhang; Wenling Zhao; Yaoxin Yang; Jin Liu; Hui Yang; Tao Zhu; Yu Li; Cheng Zhou
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.